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ABSTRACT Thegenotypeofthehostisoneofseveralfactorsinvolvedinthepathogenesisofaninfectiousdiseaseandmaybea
keyparameterintheepidemiologyofhighlypathogenicH5N1inﬂuenzavirusinfectioninhumans.Genepolymorphismsmay
affecttheviralreplicationrateoralterthehost’simmuneresponsetothevirus.Inhumans,itisunclearwhichaspectdictatesthe
severityofH5N1virusdisease.ToidentifythemechanismunderlyingdifferentialresponsestoH5N1virusinfectioninageneti-
callydiversepopulation,weassessedthehostresponsesandlungviralloadsin21inbredmousestrainsuponintranasalinocula-
tionwithA/HongKong/213/03(H5N1).Resistantmousestrainssurvivedlargeinoculawhilesusceptiblestrainssuccumbedto
infectionwith1,000-to10,000-fold-lowerdoses.Quantitativeanalysisoftheviralloadafterinoculationwithanintermediate
dosefoundsigniﬁcantassociationswithlethalityasearlyas2dayspostinoculation,earlierthananyotherdiseaseindicator.The
increasedviraltitersinthehighlysusceptiblestrainsmediatedahyperinﬂamedenvironment,indicatedbythedistinctexpres-
sionproﬁlesandincreasedproductionofinﬂammatorymediatorsonday3.Supportingthehypothesisthatviralloadrather
thananinappropriateresponsetotheviruswasthekeyseverity-determiningfactor,weperformedquantitativereal-timePCR
measuringthecytokine/viralRNAratio.Nosigniﬁcantdifferencesbetweensusceptibleandresistantmousestrainswerede-
tected,conﬁrmingthatitisthehostgeneticcomponentcontrollingviralload,andthereforereplicationdynamics,thatispri-
marilyresponsibleforahost’ssusceptibilitytoagivenH5N1virus.
IMPORTANCE HighlypathogenicH5N1inﬂuenzavirushascirculatedinSoutheastAsiasince2003buthasbeenconﬁrmedinrela-
tivelyfewindividuals.Ithasbeenpostulatedthathostgeneticpolymorphismsincreasethesusceptibilitytoinfectionandsevere
disease.Themechanismsandhostproteinsaffectedduringseverediseaseareunknown.Inbredmousestrainsvaryconsiderably
intheirabilitytoresistH5N1virusandwereusedtoidentifytheprimarymechanismdeterminingdiseaseseverity.Afterinocu-
lationwithH5N1,resistantmousestrainshadreducedamountsofvirusintheirlungs,whichsubsequentlyresultedinlower
productionofproinﬂammatorymediatorsandlesspathology.Wethereforeconcludethatthehostgeneticcomponentcontrol-
lingdiseaseseverityisprimarilyinﬂuencingviralreplication.Thisisanimportantconcept,asitemphasizestheneedtolimit
virusreplicationthroughantiviraltherapiesanditshowsthatthehyperinﬂammatoryenvironmentissimplyareﬂectionofmore
viralgeneticmaterialinducingaresponse.
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G
eneticpolymorphismswithinthegenomeoftheinfectedhost
play an important role in the response to and outcome of
microbial infections. In humans, several polymorphisms that af-
fect HIV, hepatitis C virus (HCV), and herpes simplex virus
(HSV) pathogenesis (1–6) have been described. However, very
few data are available on how host genetic differences inﬂuence
thecourseofinﬂuenzaAvirusinfection,andwhatisavailableisat
best inconclusive. Studies on highly pathogenic H5N1 inﬂuenza
virus in Asia support the notion of host genetic polymorphisms
affecting susceptibility to H5N1 virus (7, 8), with a high propor-
tionofinfectedcontactsbeinggeneticallyrelatedtotheindexcase
within family clusters. Also, during the 2009 H1N1 virus pan-
demic,individualsofindigenousdescentintheAmericas,Austra-
lia, and the Paciﬁc had higher hospitalization rates than did the
overall population (9, 10). Although the increased incidence of
risk factors such as diabetes and asthma may have contributed to
this difference, gene polymorphisms likely played an important
role in susceptibility to inﬂuenza virus.
Despite the evidence favoring a role for host genetic polymor-
phisms in susceptibility to inﬂuenza virus infection, no human
polymorphismshavebeendiscovered.Moreimportantly,wehave
yet to understand the mechanistic basis for the difference in
pathogenesis: does the genetic change in susceptible hosts allow
for increased replication dynamics of the virus or an altered im-
mune environment, or does it completely change the hosts’ re-
sponse to the pathogen independently of viral burden? Existing
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infection with low- or highly pathogenic viruses (11–17) would
suggest that individuals with severe disease have an aberrant im-
mune response to the virus. Alternatively, the genetic differences
between the hosts allow for an increased virus replication rate,
resulting in the induction of a more vigorous immune response.
Inhumans,H5N1viruspathogenesisischaracterizedbyhighviral
loadandincreasedproductionofproinﬂammatorycytokinescul-
minatinginseverediseaseandoftendeath(i.e.,60%mortalityrate
in humans) (12, 15). Due to the correlative nature of the 2 para-
meters, it is unclear how they are linked and how each affects
survival after infection. The importance of replication dynamics
was recently highlighted in a paper by Hatta et al. demonstrating
thatthemorevirulentH5N1virusalsohadthehighestreplication
rate of the viruses studied (18).
To increase our understanding of H5N1 virus pathogenesis
and to study the effects of host genetic variation, we initiated a
large systematic effort to deﬁne the underlying mechanism in-
volved in susceptibility or resistance to inﬂuenza virus infection.
This knowledge is crucial for the identiﬁcation of genes or gene
networks associated with differences in pathogenesis. In sum-
mary, H5N1 virus pathogenesis in genetically diverse hosts is
largelydeterminedbythehostfactorscontrollingviralloadinthe
lungs. Increased viral loads initiate the production of excessive
amounts of proinﬂammatory cytokines, causing tissue damage
and ultimately mortality of the susceptible host.
RESULTS
H5N1 virus pathogenic phenotypes among inbred mouse
strains. We experimentally inoculated 21 mouse strains with the
highly pathogenic H5N1 inﬂuenza A virus A/Hong Kong/213/03
(HK213) and monitored the animals for 30 days thereafter for
signs of morbidity and mortality. The 50% mouse lethal dose
(MLD50) values varied from 40 50% egg infective doses (EID50)
for the inﬂuenza virus-susceptible strain DBA/2S (susceptibility
indicated by “S”) to more than 106 EID50 for the inﬂuenza virus-
resistantstrainsBALB/cRandBALB/cByR(resistanceindicatedby
“R”) (Fig. 1).
Several strains were resistant to the high-dose challenge and
had MLD50 values between 105 and 106 EID50. Others were con-
sidered either susceptible (MLD50  104 EID50) or highly suscep-
tible (MLD50  103 EID50). The diversity in pathogenic potential
of a single highly pathogenic H5N1 virus prompted us to deﬁne a
dose of virus that was lethal to the susceptible mouse strains but
induced only mild morbidity without mortality in the resistant
strains. Thus, we set the dose of 104 EID50 as the cutoff for H5N1
virus resistance/susceptibility and subsequently used it in all host
response experiments.
Transfer of hematopoietic cells from resistant strains does
not rescue the pathogenic phenotype of susceptible strains. An
appropriate immune response mediated by hematopoietic cells is
essentialforclearanceofinﬂuenzavirusesandsubsequentsurvival
of the infected host. To test whether susceptible mouse strains
have an inferior immune response due to one or more genetic
polymorphisms,wegeneratedchimericDBA/2Smicewhosebone
marrow (BM) was replaced with that of C57BL/6R (DBA/2C57),
BALB/cR (DBA/2BALB), or DBA/2S (DBA/2DBA/2) as a control.
Twelve weeks post-BM transfer, successful engraftment was de-
termined using strain-speciﬁc cell surface markers. The chimeric
miceweresubsequentlyinfectedwith1of2dosesofHK213virus.
At a dose of 104 EID50, the DBA/2C57 and DBA/2BALB mice suc-
cumbed to infection approximately 7 to 8 days postinoculation
(dpi).Thisﬁndingwassimilartothatseeninage-matchedDBA/2
control mice and DBA/2DBA/2 mice (Fig. 2A). Intranasal inocula-
tion with a 10-fold-lower dose (103 EID50) produced similar re-
sults: DBA/2BALB mice died around the same time (postinocula-
tion day 8) as did the DBA/2DBA/2 control mice. DBA/2C57 mice
survived a few days longer; however, all of the mice had died by
day 12 postinoculation (Fig. 2B). Thus, the immune response of
hematopoietic origin from resistant mouse strains was unable to
rescue the phenotype of a susceptible strain, consistent with the
hypothesis that the genetic polymorphism(s) affecting H5N1 vi-
rus pathogenesis in susceptible mouse strains promotes viral rep-
lication in the epithelial cells of the respiratory tract.
RNA expression proﬁle early after H5N1 virus infection dif-
ferentiatessusceptiblefromresistantmousestrains.Toidentify
differencesinthemolecularresponsestoHK213virusinfectionin
the susceptible and resistant mouse strains, we performed large-
scale expression analysis of lung tissue before and at various time
points after inoculation in 3 susceptible strains (DBA/2S, 129/
SvImS, and A/JS) and 3 resistant strains (SMR, C57BL/6R, and
BALB/cR). Probes (26,000) that were detected in one or more
strains at any time point after infection were included in subse-
quent analyses. Prior to detailed gene and pathway expression
analysis, we performed an unsupervised principal component
analysis (PCA) to identify similarities or differences in overall
geneexpressionbetweenstrainsofmicebeforeinoculationand1,
3 and 7 days postinoculation (dpi). If all biological replicates of a
particularcondition(mousestrain)formaclusterandarelocated
elsewhere on the plot compared to the rest of the data, that par-
ticular mouse strain is considered to have a distinct expression
proﬁle. Our goal was to identify similarities and differences
amongthestrainsandcorrelatethosewithourdiseasephenotype.
Prior to infection or shortly thereafter (day 1 postinfection), no
FIG 1 Pathogenic proﬁle of 21 inbred mouse strains inoculated with highly
pathogenic H5N1 inﬂuenza A virus. The 50% mouse lethal dose (MLD50)o f
A/HongKong/213/03virusisshown.Adoseof104EID50(dottedline)wasset
to distinguish inﬂuenza virus-resistant from inﬂuenza virus-susceptible
mouse strains and used throughout the work to assess biological parameters
associated with severity of disease and mortality.
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throughouttheplot(Fig.3).Atday3postinfection,theexpression
proﬁles of the mice clustered into 3 groups. Group 1 (red circle)
contained only highly susceptible strains (DBA/2S and 129/
SvImS). Group 2 (green circle) was composed of resistant strains
(C57BL/6R and BALB/cR) only. Group 3 (blue circle) was com-
posed of a susceptible strain and a resistant strain (A/JS and SMR,
respectively) and was situated between groups 1 and 2 on the
second component. By day 7, the clustering of susceptible (group
1) and resistant (group 2) strains remained intact. More impor-
tantly, the susceptible strain in group 3, A/JS, had joined group 1,
andtheresistantstrain(SMR)wasfoundincloseproximitytothe
other resistant strains of group 2. These plots clearly indicate that
a gene expression signature is associated with death or survival in
these mice but also that these signatures are not necessarily ﬁxed
until later in the infectious process.
Pathway analysis of the response to H5N1 virus infection in
inbred mouse strains. To identify qualitative and quantitative
differences in the host responses associated with survival, we
probed the transcriptomes of susceptible and resistant mouse
strainsbeforeandafterinoculationwithH5N1virus.Becauseour
phenotype occurred after H5N1 virus infection, we focused on
geneswhoseexpressionincreasedordecreased2-foldcompared
to that in uninfected controls in at least two of the three suscepti-
bleorresistantmousestrains;thisapproachyieldedacomprehen-
sive set of 2,038 genes.
At day 1 postinoculation, 76 genes were differentially ex-
pressed,ofwhichthemajority(64)weresharedbythesusceptible
and resistant strains (see Fig. S1A in the supplemental material).
By day 3, the number of differentially expressed genes increased
dramatically to 829, and 569 (68.6%) of those were shared by the
twogroups.Surprisingly,only28(3.4%)geneswereuniquelyup-
or downregulated in the resistant strains and 232 (70.5%) were
foundonlyinthesusceptiblestrains.Theseincludedseveralgenes
that encode cytokines associated with increased inﬂammation,
e.g.,Il28b,Ifna4,Ifna5,andTnfrsf1b.Similarresultswerefoundat
day 7, with 582 of 1,084 (53.7%) genes differentially expressed in
the susceptible strains only. Overall, these data suggest that the
resistant mouse strains do not express a unique set of genes or a
pathway(s) controlling replication or disease. Rather, the differ-
ence in expression proﬁles identiﬁed by PCA (Fig. 3) was caused
by altered or increased gene expression in the susceptible mouse
strains.
Next, we performed pathway analysis of the up- or downregu-
lated genes within each mouse strain. At day 1 postinoculation,
gene sets in 5 of 6 strains were enriched for the glutathione path-
way (SMR was the exception). By day 3, the identiﬁed pathways
were similar among all 6 strains (see Fig. S1B in the supplemental
material), with signiﬁcant P values for all the well-known path-
ways, including the cytokine-cytokine receptor interaction path-
way,Toll-likereceptorpathway,NOD-likereceptorpathway,and
chemokine signaling pathway. The increased expression of many
of these pathway-associated genes in all strains suggested that the
difference in resistance to H5N1 virus pathology is not due to a
defect in innate or antiviral immune signaling in the susceptible
strains.Onthecontrary,ouranalysisofthetotalnumberofgenes
identiﬁed within a particular pathway (Fig. S1C) showed many
moreupregulatedgenesintheDBA/2Sand129/SvImSstrainsthan
inotherstrains.Atday7postinfection,wefoundanenrichedgene
expression proﬁle in the resistant mouse strains that is associated
with systemic lupus erythematosus, cell adhesion molecules, the
antigen processing and presentation pathway, and the graft-
versus-host disease pathway. This proﬁle is indicative of adequate
virus-speciﬁc T- and B-cell responses in these mice. In contrast,
the 3 susceptible strains continued to have many cytokine genes
upregulated, as evidenced by the low P value for the cytokine-
cytokine receptor interaction pathway (Fig. S1B and S1C; Ta-
ble S1).
Finally, we performed statistical analysis on the array data to
identify genes whose expression values correlated with the PCA
clustering observed on days 3 and 7 postinoculation (see Table S2
in the supplemental material). The majority of the 85 identiﬁed
genes belonged to proinﬂammatory pathways, including
cytokine-cytokine receptor pathways, the Jak-Stat pathway, and
innate sensing pathways like the Toll-like receptor pathway. To
summarize, the difference between resistant and susceptible
A
B
FIG 2 The hematopoietic component does not confer resistance in suscep-
tible strains. Chimeric DBA/2S mice containing bone marrow from resistant
(C57BL/6R or BALB/cR) or susceptible (DBA/2S) mice were inoculated with
104 EID50 (A) or 103 EID50 (B) of A/Hong Kong/213/03 virus and monitored
for morbidity and mortality for 21 days.
Host Genetic Factors Affect Viral Load
September/October 2011 Volume 2 Issue 5 e00171-11
® mbio.asm.org 3strains is predominantly quantitative, with the excessive produc-
tion of proinﬂammatory cytokines in the susceptible strains most
likelyaffectingdownstreaminductionofrobustadaptiveimmune
responses. The overrepresentation of proinﬂammatory genes in
thesusceptiblestrainsisindicativeofongoingviralreplicationand
suggests higher replication rates and higher viral loads in these
strains.
Increased production of inﬂammatory mediators in suscep-
tible mouse strains. Many of the genes associated with severe
disease that were identiﬁed by expression analysis are considered
proinﬂammatory. Although inﬂammation is important for the
induction of an innate and adaptive immune response, too much
inﬂammation can be pathological and exacerbate disease. To val-
idate the expression data and demonstrate increased production
of proinﬂammatory mediators in the susceptible strains, we mea-
sured the production of CCL2, alpha interferon (IFN-), IFN-,
tumor necrosis factor alpha (TNF-), CXCL2, and CSF3 after
inoculation with 104 EID50 in 3 susceptible mouse strains (DBA/
2S, 129/SvImS, and A/JS) and 3 resistant strains (SMR, C57BL/6R,
and BALB/cR). At day 3 postinfection, lung homogenates of sus-
ceptible strains contained signiﬁcantly higher concentrations of
proinﬂammatorycytokinesthandidthoseofmostoftheresistant
strains (Fig. 4); however, intriguing patterns emerged. The con-
centration of CSF3 was signiﬁcantly higher in all susceptible
strainsandintheSMRstrain,which,basedonexpressionanalysis,
clustered with the susceptible A/JS strain. A similar pattern was
found for IFN- and IFN-. In contrast, the production levels of
CCL2 and CXCL2 were signiﬁcantly higher in the DBA/2S and
129/SvImS strains than in the other 4 strains. Finally, we found
signiﬁcantlyhigherlevelsofTNF-inthesusceptiblestrainsthan
in the resistant strains. The production of certain cytokines, i.e.,
CCL2, TNF-, and CXCL2, was signiﬁcantly correlated with the
MLD50 (P  0.01; R2  0.77, 0.96, and 0.72, respectively). These
results were similar to those identiﬁed earlier by array analysis.
Viral load determines the outcome after infection with the
HK213virus.Wehypothesizedthatincreasedpathogenicitycou-
pled with enhanced inﬂammation in the susceptible strains may
betheresultofhigherviraltiters.Totestthishypothesis,wequan-
tiﬁed the amount of infectious virus at days 2, 4, and 7 postinoc-
ulation with 104 EID50 of HK213 in the lungs of the 6 mouse
FIG 3 Principal component analysis identiﬁes the gene expression proﬁle associated with severity of H5N1 virus disease. Principal component analysis using
~26,000 probes in lung tissue RNA of DBA/2S, 129/SvImS, A/JS,S M R, C57BL/6R, and BALB/cR mice prior to infection (control) and on days 1, 3, and 7 after
inoculationwith104EID50ofA/HongKong/213/03.EachdotrepresentstheRNAexpressionproﬁleofasinglemouse.Coloredcirclesindicatethethreeclusters
ofhighlysusceptible(red),intermediatesusceptible(blue),andresistant(green)mousestrains.Thex,y,andzaxescorrespondtoprincipalcomponents1,2,and
3, respectively.
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virus titer ranged from 104.9 50% tissue culture infective doses
(TCID50)/ml in C57BL/6R and SMR strains to 106.5 TCID50/ml in
the DBA/2S strain (Table 1). The virus titer differed signiﬁcantly
between susceptible and resistant strains (P  0.05), and it corre-
lated well with the MLD50 (R2  0.70, P  0.05). In addition, we
found signiﬁcant associations between virus titer and MLD50 on
d a y4( R2  0.82, P  0.05) and day 7 (R2  0.81, P  0.05). To
estimatetheviralburdenoveraperiodof7days,wecalculatedthe
area under the curve (AUC) for all 6 strains; again, we found a
signiﬁcant correlation with MLD50 (R2  0.87, P  0.01).
To conﬁrm the association between high viral load and in-
creased susceptibility, we applied computer-assisted immunohis-
tochemicalanalysisoflungtissuefrom3susceptiblestrains(DBA/
2S, 129/SvImS, and A/JS) and 2 resistant strains (C57BL/6R and
BALB/cR) to detect the frequency of inﬂuenza A virus
nucleoprotein-positive(NP)nucleiincrosssectionsofanentire
formalin-ﬁxedlung.Despitethesmallnumberofmiceusedinthis
experiment,itwasclearthatthesusceptiblestrainshadmoreNP
nuclei than did the resistant strains on days 2, 4, and 7 postinfec-
tion (see Table S3 in the supplemental material).
Todemonstratetheeffectofincreasedviralloadonproinﬂam-
matory cytokine production and survival, we inoculated DBA/2S
and C57BL/6R mice with a 100-fold-higher dose (106 EID50). As
predicted, the production of CCL2 and TNF- 3 dpi was signiﬁ-
cantlyhigher(P0.01)(seeFig.S4inthesupplementalmaterial)
inthemiceinoculatedwith106EID50thaninthemiceinoculated
with 104 EID50. More importantly, the amounts of CCL2 and
TNF-producedinthelethallyinfectedC57BL/6Rmiceweresim-
ilar to those found in DBA/2S mice infected with a much lower,
but for this strain similarly lethal, dose of 104 EID50.
Elevated production of proinﬂammatory mediators corre-
lateswithincreasedviralloadinsusceptiblemousestrains.The
newfound associations between viral loads, proinﬂammatory cy-
tokine production, and outcome after infection were conﬁrmed
using quantitative real-time PCR on a select set of proinﬂamma-
torymediatorsinconjunctionwithinﬂuenzaAvirusmatrixRNA
species. Twenty-four hours postinoculation, the amount of inﬂu-
enza virus RNA was signiﬁcantly higher (analysis of variance
FIG 4 Elevated production of proinﬂammatory mediators in susceptible mouse strains after inoculation with H5N1 virus. Cytokine concentrations (pg/ml)
were measured in homogenized lung tissues of DBA/2S, 129/SvImS, A/JS,S M R, C57BL/6R, and BALB/cR mice 3 days after inoculation with highly pathogenic
A/Hong Kong/213/03 H5N1 virus. Bars represent mean cytokine production levels  SEMs. Statistical signiﬁcance (P  0.01) between the six mouse strains is
represented by letters above each column, with different letters signifying distinct statistical groups.
TABLE 1 Virus titers in the lungs of genetically diverse mouse strains
inoculated with A/Hong Kong/213/03 H5N1 virus
Mouse strain
Virus titera (log10 TCID50/ml)
Viral burdenb (AUC) Day 2 Day 4 Day 7
DBA/2S 6.5 5.7 4.8 34.6
129/SvImS 5.9 5.1 4.6 31.4
A/JS 5.8 5.0 4.0 30.0
SMR 4.9 4.6 3.2 26.1
C57BL/6R 4.9 5.0 3.6 27.8
BALB/cR 5.6 4.6 2.2 25.9
a Lung virus titers (50% tissue culture infectious doses [TCID50s]) at days 2, 4, and 7
after inoculation with 104 EID50 of A/Hong Kong/213/03 inﬂuenza virus are shown.
b Area under the curve (AUC) for inﬂuenza virus titers between days 0 and 7 after
inoculation with 104 EID50 of A/Hong Kong/213/03 inﬂuenza virus are shown.
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129SvImS, and A/JS than in the two most resistant strains,
C57BL/6R and BALB/cR (Fig. 5A). Not surprisingly the reduced
viral load in the resistant strains minimized the production of
proinﬂammatory cytokines on day 3 (Fig. 4) and allowed these
two mouse strains to cluster at the transcriptional level (Fig. 3),
displaying a “normal” inﬂammatory response to the invading
pathogen. The third resistant strain, SMR, had a high viral RNA
load at 1 dpi similar to those of the susceptible strains and there-
foreclusteredwithasusceptible(A/JS)strainatthetranscriptional
level and also produced more proinﬂammatory mediators.
Three days postinoculation, the resistant C57BL/6R and BALB/cR
strainscontinuedtohavesmalleramountsofviralRNA(ANOVA,
P  0.0001) than did the susceptible strains. In addition, the viral
load in the third resistant strain, SMR, was lower than those in all
three susceptible strains, providing further support for our hy-
pothesis that viral load dictates the pathogenic response to infec-
tion in genetically diverse mice. Interestingly, the increase in
amount of viral RNA between 1 and 3 dpi is signiﬁcantly lower (P
 0.01) in the resistant strains than in the susceptible strains
(Fig. 5B), conﬁrming that lower viral load and early control of
viral replication are key to minimizing disease and promoting
survival.
To exclude the possibility that excessive production of cyto-
kines promotes virus replication and therefore increases the viral
load,wedeterminedthemRNAlevelsofseveralproinﬂammatory
FIG5 Viralloaddeterminesproinﬂammatorycytokineproductioningeneticallydiversemice.(A)Higherviralload(CTvalue)insusceptiblemousestrains
(DBA/2S,129SvImS,andA/JS)thanintheresistantstrainsC57BL/6RandBALB/cR1and3dayspostinoculation(dpi)with104EID50ofH5N1virus.Dotsindicate
individualmice,andtheaveragevaluesSEMsareindicatedbythesolidbars.(B)Resistantmousestrains(SMR,C57BL/6R,andBALB/cR)moreeffectivelylimit
virusreplicationbetween1and3dpithandosusceptiblestrains.BarsrepresentaveragefoldincreasesinviralRNASEMs.(C)Higherviralloadinsusceptible
mouse strains plus SMR triggers an increase in production of proinﬂammatory mediators CCL2, IFN-1, and TNF- at 3 dpi (gray bars; P  0.01) but not at 1
dpi (black bars; P  0.05). Bars represent average CT values  SEMs.
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1 postinoculation, the increases in expression of ccl2, ifnb1, and
tnfa (threshold cycle [CT] value) were similar between all 6
mouse strains (Fig. 5C; see also Fig. S3 in the supplemental mate-
rial), indicating that the production of proinﬂammatory cyto-
kinesisnotresponsiblefortheobserveddifferenceinviralRNAat
3 dpi. At 3 dpi, the fold increase in mRNA associated with ccl2,
ifnb1, and tnfa was signiﬁcantly lower (P  0.001) in the resistant
strains C57BL/6R and BALB/cR than in the three susceptible
strains plus SM/JR, providing further support that early viral load
determines the inﬂammatory response and as such the outcome
after infection.
To demonstrate that the genetic differences do not affect the
production of proinﬂammatory cytokines per unit of viral RNA,
we computed the ratio between cytokine RNA and viral RNA
CTvalues(seeFig.S3inthesupplementalmaterial).At1and3
dpi,theratiosforIFN-1weresimilaracrossallstrainstested.For
the other cytokines, we observed signiﬁcant differences in the ex-
pression ratios among the different mouse strains; however, lim-
ited evidence for an association of these differences with disease
severityorsusceptibilitytoH5N1virusinfectionwasfound.Com-
bined,theseanalysessuggestnotthattheincreasedsusceptibilityis
caused by an intrinsic difference in the response to infection but
rather that it is caused by a higher viral load inducing excessive
production of proinﬂammatory cytokines and hence increased
morbidity and mortality in the susceptible mouse strains.
DISCUSSION
Polymorphisms in the genome of the host play an important role
in the severity of infection with a highly pathogenic H5N1 inﬂu-
enza A virus. The mechanism dictating the difference in H5N1
pathogenicities among genetically diverse hosts is, however, un-
known. Detailed analysis of 6 H5N1 virus-infected inbred mouse
strains demonstrated that the viral load is responsible for the
heightened inﬂammation in susceptible hosts. This produces a
pathogenic environment as early as 3 days postinoculation, ulti-
mately causing the host to succumb.
Several studies have compared high- and low-pathogenic in-
ﬂuenza A viruses in various host species and, without exception,
identiﬁed a strong association between pathogenicity and exces-
sive production of proinﬂammatory mediators (16, 18–25). Two
possible mechanisms explain this difference: ﬁrst, increased rep-
licationdynamicsofthemorepathogenicvirusesmayresultinthe
infection of more epithelial cells and subsequent production of
higher levels of cytokines. Second, altered intracellular signaling
properties of viral proteins (e.g., PB1-F2, NS1, or hemagglutinin
[HA])ofthepathogenicvirusmaytriggercellstoproducemoreor
different cytokines. Although both of these mechanisms are likely
involved when comparing subtypes of inﬂuenza A viruses in a
single homogenous host species, it is not well understood how a
singlehighlypathogenicH5N1virusproducessuchvariedpathol-
ogies in genetically diverse hosts. Does the genetic change in sus-
ceptible hosts allow for increased replication dynamics or an al-
tered immune environment, or does it completely change the
hosts’ response to the pathogen independently of viral burden?
Based on the data presented, we conclude that the susceptible
host provides a milieu that allows for increased viral replication,
which subsequently induces the production of more proinﬂam-
matory cytokines and tissue damage and ultimately results in the
death of the animal. Although this study is the ﬁrst of its kind,
detailed analysis of H5N1 virus-infected humans in Vietnam also
demonstrated a signiﬁcant correlation between viral load, cyto-
kine concentration, and severity of disease (12), thereby support-
ing the conclusion that differences in pathogenesis within a single
host species are the result of variable replication dynamics.
The difference in viral load between susceptible and resistant
strains was presented very early after inoculation (24 to 48 h),
suggesting that the virus replication rate in the susceptible mouse
strainsishigherthanthatintheresistantstrains.Atthispoint,itis
unclear whether this increase in replication rate is due to an inef-
ﬁcient antiviral mechanism or to an increase in cell metabolism
and/or the availability of nutrients required for replication. The
observation that the viral load increased nearly 8-fold in the sus-
ceptible strains between 1 and 3 dpi compared to 4-fold in the
resistant strains suggests that the increased replication rate is
caused by one or more defective antiviral effector molecules in-
duced by the production of type I and II interferons shortly after
infection. Alternatively, there could be a difference in infectious
dose (50% infectious dose [ID50]) between the resistant and sus-
ceptible mouse strains due to variations such as the sialic acid
receptor content of the respiratory tract. Previously, we had
shown a 100% infection rate in a resistant strain and a susceptible
strain following inoculation with a very low dose of 100 EID50 of
HK213,suggestingthattheID50saresimilarbetweenresistantand
susceptible mice and that this is unlikely the reason for the differ-
ences observed.
The importance of replication kinetics or polymerase activity
inpathogenicityiswellestablished(18,26–30).ThePB2E627Kand
PB2D701N mutations are associated with increased polymerase ac-
tivity and faster replication; thus, viruses containing these muta-
tions are often more pathogenic in mice (18, 27, 31). Molecular
characterization of a variant PR8 virus adapted to induce severe
diseaseinMx1-positivemicefoundseveralmutationsinthepoly-
merasecomplexthatallowedthevirustogrowfasterandtherefore
be more pathogenic than its wild-type counterpart (32). A recent
comparison of A/Hong Kong/483/97 and A/Hong Kong/486/97
H5N1 viruses also surmised that replication rate regulates disease
severity and the magnitude of the virus-speciﬁc CD8 T-cell re-
sponse (18). After low-dose infection, the HK483 virus harboring
a PB2 protein with a lysine residue at position 627 grew to signif-
icantly higher titers early during infection than did the variant
containingaglutamicacidatthisposition.Thisdifferenceinviral
loads resulted in quantitative and qualitative differences in the
cytotoxic T-cell responses that could be reversed upon adminis-
tration of oseltamivir, a drug that limits viral replication. Com-
bined, these studies suggest that the replication rate of the virus
and hence viral load are responsible for the increase in inﬂamma-
tion and therefore pathogenesis of the virus. Reducing viral load
orreplicationratewillmostlikelyreducemorbidityandmortality
upon infection.
Asaresultoftheheightenedviralloadduringtheearlystagesof
infection, the immune response in susceptible mice is excessive
andcanbedetectedwithin3daysofinfection.Thisrelativelybrief
period of time has implications for potential intervention strate-
giesforseverecasesofinﬂuenzavirusinfection.Italsoexplainsthe
relatively short time period during which current commercially
available antiviral therapy has proven effective. Similar observa-
tions have been made with monoclonal antibodies, whose treat-
ment window is 3 to 4 days postinfection (33, 34). The opportu-
nity to treat susceptible mice is much shorter (less than 1 day
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postinfection[unpublisheddata]).Inourstudy,onemousestrain
that displayed an intermediate pathogenic proﬁle (SMR) recov-
ered from the infection. This ﬁnding indicates that with the right
treatmentapathogenicproﬁlecanbereversedandtheanimalcan
survive.
Clues about what biological trait is important for survival of
inﬂuenza virus infection may be found in the A/JS and SMR
strains. Although the strains had similar pathogenic expression
proﬁles, the SMR mice survived the infection while the A/JS mice
did not. The absence of glutathione metabolism pathway-
associatedgeneexpressionintheSMRmicemayprovideuswitha
mechanism for the difference in pathogenesis. Glutathione me-
tabolism gene transcription is initiated early after infection to re-
duceharmfulreactiveoxygenspecies(ROS).Micelackingafunc-
tional NADPH oxidase (Cybb-deﬁcient mice) can no longer
produce ROS, and intranasal infection with inﬂuenza virus was
shown to increase the production of proinﬂammatory cytokines
and promote cellular inﬁltration into the lungs (35, 36). Despite
theincreaseininﬂammation,Cybb-deﬁcientmicehadlowerviral
loadsandimprovedresolutionoftheinfection,similartowhatwe
observed in SMR mice. As such, further studies to determine the
production of ROS and proinﬂammatory cytokines and to mea-
sure the induction of the glutathione metabolism response path-
way in activated macrophages of SMR and C57BL/6R mice would
be of interest. A lack of ROS production, minimal expression of
glutathione response genes, and reduced proinﬂammatory cyto-
kineproductionintheSMmousemacrophageswillformthebasis
for future studies into the role of ROS in inﬂuenza virus patho-
genesis. An alternative explanation is the presence of one or more
genetic changes affecting viral clearance. An example of this is the
hemolytic complement (Hc) gene, which affects T-cell responses
and therefore viral load at later time points during infection. The
SMR strain expresses a fully functional Hc gene; thus, viral load is
reduced, inﬂammation is limited, and the animals are more likely
to survive infection than are A/JS mice, which do not express a
fully functional Hc gene.
Although the susceptible strains and SMR produced large
amounts of proinﬂammatory cytokines (e.g., IFN- and CSF3),
certain cytokines were predominantly produced in the extremely
susceptible strains such as DBA/2S and 129/SvImS. The excessive
production of certain proinﬂammatory mediators such as CSF3
and type I interferons may cause a mild, controllable form of
inﬂammation, though the addition of a second signal such as
CCL2 and/or TNF- may create an uncontrollable cascade of
events resulting in tissue damage and diminished adaptive im-
mune responses in these mice. Results from in vitro experiments
suggest that IFN- and TNF- act synergistically to induce a re-
sponse quantitatively and qualitatively different from that of ei-
ther cytokine alone (37, 38). Also, TNF- affects morbidity after
H5N1 virus infection (17, 39).
Whilethecurrentstudyfocusedonidentifyingthemechanism
of severe disease, e.g., virus replication, there is obvious merit in
identifying the speciﬁc genetic polymorphisms responsible for
this phenotype. The MLD50 curve for highly pathogenic H5N1
virus (Fig. 1) suggests that several genetic polymorphisms are in-
volved. A similar complexity was previously identiﬁed with the
recombinant inbred BXD strain family, in which 3 genetic loci
contribute to the response to inﬂuenza virus infection (40). To
identify the responsible polymorphisms, genetic tools like the
BXD RI strains, consomic strain sets, or the Collaborative Cross
will be extremely useful (41–44). Several of the candidate genes
identiﬁed in our earlier BXD study were evaluated for their asso-
ciation with disease severity in our larger mouse panel using the
available single nucleotide polymorphism (SNP) data. Hemolytic
complement,onQivr2,didnotdifferentiatetheresistantandsus-
ceptible mouse strains. Qivr7 contains several potential antiviral
genes (Trim genes); however, there are not enough public SNP
data available to do the analysis. The candidate genes on Qivr11
(Grn,Iﬁ35,andDhx58)allassociatedsigniﬁcantly(P0.01)with
diseaseseverityandarecurrentlyunderinvestigationfortheirrole
in inﬂuenza virus pathogenesis. Finally, none of the candidate
genesonQivr17(Xdh,Eif2ak2,Emilin2,andNlrc4)separatedwith
our phenotype.
In conclusion, gene polymorphisms in the genome of the in-
fectedhostcanhaveaprofoundimpactonthecourseofanH5N1
inﬂuenza virus infection. Although featured as too much inﬂam-
mation with excessive production of proinﬂammatory cytokines,
the pathogenicity of inﬂuenza virus infection is rooted in in-
creased virus titers in the lungs of the susceptible hosts.
MATERIALS AND METHODS
Inbred mouse strains and inﬂuenza A virus. Female mice (6 to 8 weeks
old)fromthefollowingstrainswerepurchasedfromJacksonLaboratories
(Bar Harbor, ME) and housed in the Animal Resource Center at St. Jude
Children’s Research Hospital: C57BL/6J (stock no. 664), BALB/cJ (stock
no.651),SM/J(stockno.687),DBA/2J(stockno.671),FVB/NJ(stockno.
1800), LP/J (stock no. 676), NZB/BlnJ (stock no. 684), C3H/HeJ (stock
no.659),BALB/cByJ(stockno.1026),AKR/J(stockno.648),B10.D2-H2/
oSnJ (stock no. 461), A/J (stock no. 646), A/HeJ (stock no. 645), 129/
SvImJ (stock no. 2448), MRL/MpJ (stock no. 486), NZW/LacJ (stock no.
1058), BTBR T tf/J (stock no. 2282), KK/HlJ (stock no. 2106), 129X1/
SvJ (stock no. 691), DBA/1J (stock no. 670), and NOD/ShiLtJ (stock no.
1976).Strainselectionwasbasedonrepresentationinlargemousegenetic
databases like Haplotype Mapping by Roche Pharmaceuticals, Ancestry
MappingbyPerlegen,andfull-genomesequencingbytheSangerInstitute
(45–47).Themicereceivedwaterandfoodadlibitum,andallexperimen-
tal procedures were approved by the Animal Care and Use Committee of
St. Jude Children’s Research Hospital.
A reverse genetics variant of A/Hong Kong/213/03, a highly patho-
genic H5N1 inﬂuenza A virus, was propagated in 10-day-old embryo-
natedchickeneggs.Theallantoicﬂuidcontainingtheinfectiousviruswas
harvested, and the infectious virus titer was determined in eggs. The
A/Hong Kong/213/03 virus (H5N1) variant contains 7 segments of
A/Hong Kong/213/03 and 1 segment of A/Chicken/Hong Kong/52/03
H5N1virus(40).ThisvirusisreferredtoasHK213throughoutthepaper.
InﬂuenzaAvirusinfectionofmice.Experimentalinoculationofmice
with HK213 virus was done intranasally in 30 l phosphate-buffered sa-
line (PBS) as described previously (40, 48). MLD50 experiments were
repeated, and the reported results were calculated from the cumulative
results.
GenerationofbonemarrowchimeraDBA/2mice.CD4andCD8
cells were depleted in vivo after intraperitoneal (i.p.) injection of DBA/2S,
C57BL/6R, and BALB/cR donor mice with anti-CD4 and anti-CD8 anti-
bodies.BMwasthencollectedfromthefemursofthesemice,andapprox-
imately 6 million cells were injected intravenously into 9-Gy-irradiated
DBA/2S mice. The mice were treated with Sulfatrim for 3.5 weeks to pre-
vent any opportunistic infection.
At 12 weeks postengraftment, a small volume of peripheral blood was
collected and subjected to ﬂow cytometric analysis to test for the expres-
sion of cell surface markers of the respective donor mouse strains. In the
C57BL/6R BM-recipient mice, we measured the percentage of H-2b
(C57BL/6) and H-2k (DBA/2) cells within the CD3 T-cell population.
In the BALB/cR BM-recipient mice, we measured the percentage of
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population. Animals in which more than 90% of the T or B cells were
donor-derived cells were considered successful BM chimeras.
Lung viral titers and immunohistochemistry. Following intranasal
inoculation with 104 EID50 of HK213 virus, lungs were harvested on days
2, 4, and 7 postinfection, and virus titers were determined on Madin-
Darby canine kidney cells (40). At each time point, 4 to 6 animals from
each mouse strain were used. The average virus titer was calculated, and
the AUC was calculated between days 0 and 7 postinfection.
Immunohistochemical analysis was performed on formalin-ﬁxed
lung tissue harvested from HK213 virus-infected or uninfected DBA/2S,
129/SvImS, A/JS, C57BL/6R, and BALB/cR mice, as described previously
(40). Digital images were obtained with a ScanScope (Aperio, Vista, CA),
and the percentage of NP-positive nuclei was determined with ImageS-
cope (Aperio, Vista, CA) using a nucleus-based algorithm.
Cytokine analysis. Lungs from 6 strains of mice inoculated with 104
EID50 of HK213 virus were harvested on day 3 postinfection and homog-
enized in 1.0 ml PBS for two 30-s intervals at 30 Hz (TissueLyser II;
Qiagen, Valencia, CA). After centrifugation for 30 s at 16,000  g, the
supernatant was collected, divided into aliquots, and stored at 80°C.
The homogenates were subsequently thawed to quantify the amounts of
CCL2,TNF-,CSF3,andCXCL2inthelungsofinfectedanimalsbyusing
Quantikineenzyme-linkedimmunosorbentassay(ELISA)kits(R&DSys-
tems, Minneapolis, MN). The amounts of IFN- and - in the lung were
determinedwiththerespectiveELISAkits(PBLLaboratories,Piscataway,
NJ). For each cytokine at a given time point, 4 to 6 animals were tested,
and the average concentration  standard error of the mean (SEM) is
reported.
RNA isolation and functional genomics. Six mouse strains, DBA/2S,
129SvImS, A/JS,S M R, C57BL/6R, and BALB/cR, were selected for an ex-
tensive RNA expression analysis before and after inoculation with 104
EID50 of HK213 virus. Lungs were isolated in 2 batches from uninfected
mice and infected mice at days 1, 3, and 7 postinfection. RNA was ex-
tracted using TRIzol (Invitrogen, Carlsbad, CA), as previously reported
(40) and submitted to a DNA cleanup protocol (Qiagen). Next, microar-
ray analysis was done on RNA obtained from DBA/2S, 129SvImS, A/JS,
SMR, C57BL/6R, and BALB/cR mice, using Illumina MouseWG-6 v1.1
ExpressionBeadChips(Illumina,SanDiego,CA).PCAanalysisidentiﬁed
a large batch effect; however, both batches included uninfected samples,
which allowed us to calculate fold differences in gene expression. Also,
batches were done according to the day postinfection, and all 6 strains
were assessed simultaneously for each day.
Before analysis, probes without a signal (i.e., detection P value of
0.05) in any of the 104 samples were removed from the data set. Signal
values were ln-start transformed, ln(signal  20), to stabilize variance
acrosstherangeofintensitiesandapproximatenormalitiesinpreparation
for parametric tests. Using Partek Genomics Suite 6.3, we visualized the
structure of the data via PCA. As a result of the complexity of the disease,
we compared expression patterns of genes up- or downregulated in most
of the susceptible or resistant strains. For a gene to qualify for an individ-
ual strain, we required a 2-fold increase or decrease in expression in the
majorityoftheindividualsamplesforthatstrainonthatday.Onceagene
qualiﬁed for a particular strain, we next assessed whether that gene was
shared among the majority of the resistant or susceptible (2/3 or 3/4)
mousestrains.Pathwayanalysiswasperformedusingtheonlinebioinfor-
matics tool DAVID (49).
Quantitative real-time PCR. Samples of cDNA were prepared from
lung tissue RNA (200 ng) by using Superscript III (Invitrogen) and random
hexamersandusedforquantitativereal-timePCR.TheCTvaluesformurine
interleukin-6 (IL-6) (Mm00446190_m1), CCL2 (Mm00441242_m1), CCL4
(Mm00443111_m1), IFN-1 (Mm00439552_s1), TNF-
(Mm99999068_m1), CSF3 (Mm00438334_m1), and -actin were deter-
mined using commercially available primer-probe pairs from Applied Bio-
systems (Foster City, CA). To quantify the amount of virus in each RNA
sample,weusedthecDNApreparedwithrandomhexamersincombination
with a primer probe mix that was speciﬁc for the matrix gene (50). Baseline
levels of each cytokine (CT value) were determined after normalization
against -actin, and the increase in expression (CT value) was calculated.
No RNA species for IFN-1, CSF3, or inﬂuenza virus matrix RNA were de-
tectedpriortoinfection.Tocalculatetheincrease,weusedaCTvalueof40for
theuninfectedsamples.RNAsamples(n3to4)weretestedforeachstrain
and time point prior to or after infection with HK213 virus.
Statistical analysis. Statistical analysis of differences in lung virus ti-
ters was determined by a Student t test following ln transformation of the
data. Cytokine and chemokine production and quantitative PCR results
were analyzed using a Student t test or ANOVA when comparing more
than two groups. For Fig. 4, statistical signiﬁcance between the six mouse
strains is represented by letters above each column, with different letters
signifyingdistinctstatisticalgroups.Linearregressionanalysesweredone
to analyze the viral load (log10 TCID50/ml and CT value) with MLD50
(log10 EID50). P values less than 0.05 were considered signiﬁcant.
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